Eton Pharmaceuticals (ETON) Construction in Progress (2018 - 2022)
Eton Pharmaceuticals' (ETON) quarterly Construction in Progress came in at $12000.0 in Q4 2022, little changed quarter-over-quarter from $12000.0 in Q1 2022.
Analysis
Eton Pharmaceuticals (ETON) Construction in Progress (2018 - 2022) Analysis & Trends
Eton Pharmaceuticals has disclosed Construction in Progress across 4 years of filings, most recently posting $12000.0 for Q4 2022.
- In Q4 2022, Construction in Progress changed N/A year-over-year to $12000.0; the TTM figure through Dec 2022 stood at $12000.0 (changed N/A YoY), while the FY2022 annual figure was $12000.0, changed N/A from the prior year.
- Construction in Progress came in at $12000.0 for Q4 2022 at Eton Pharmaceuticals, roughly flat from $12000.0 in the prior quarter.
- In the past five years, Construction in Progress ranged from a high of $873000.0 in Q1 2019 to a low of $1000.0 in Q3 2020.
- Average Construction in Progress over 4 years is $175750.0, with a median of $10500.0 recorded in 2019.
- The largest YoY upside for Construction in Progress was 66.67% in 2020 against a maximum downside of 99.54% in 2020.
- Over 4 years, Construction in Progress stood at $492000.0 in 2018, then sank by 98.17% to $9000.0 in 2019, then slumped by 88.89% to $1000.0 in 2020, then jumped by 1100.0% to $12000.0 in 2022.
- Per Business Quant data, the three most recent Construction in Progress figures were $12000.0 in Q4 2022, $12000.0 in Q1 2022, and $1000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | - |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | - |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Eton Pharmaceuticals | 1.63 Bn | 1.60 Bn | 25.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 12,000.00 |
| Mar 31, 2022 | 12,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 4,000.00 |
| Dec 31, 2019 | 9,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Mar 31, 2019 | 873,000.00 |
| Dec 31, 2018 | 492,000.00 |